SCHEMBL5780409

SCHEMBL5780409

O=S(=O)(Nc1cc(Cl)c2c(c1)CCNCC2)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.66
HTR2C P28335 7/20 0.55
HTR2B P41595 6/20 0.55
ALDH1A1 P00352 2/20 0.49
PKM P14618 2/20 0.49
GAA P10253 1/20 0.49
ALOX15 P16050 1/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PNMT P11086 1/20 0.45
HTR2A P28223 2/20 0.44
IL1RN P18510 1/20 0.44
KEAP1 Q14145 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
MLNR O43193 1/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
CYP3A4 P08684 1/20 0.44
PGR P06401 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5778392 0.85 HTR6 (0.66) HTR6HTR2CHTR2BALDH1A1PKM
SCHEMBL5778007 0.84 LMNA (0.50) HTR6HTR2CHTR2BPKMPGR
SCHEMBL6651572 0.84 HTR6 (0.52) HTR6HTR2CHTR2BALDH1A1PKM
SCHEMBL5781306 0.80 HTR6 (1.00) HTR6HTR2CHTR2BALDH1A1PKM
SCHEMBL10357482 0.75 HTR6 (0.84) HTR6HTR2CHTR2BALDH1A1PKM
SCHEMBL7452220 0.75 HTR6 (0.84) HTR6HTR2CHTR2BALDH1A1PNMT
SCHEMBL29985647 0.74 GAA (0.65) HTR6ALDH1A1PKMGAAALOX15
Hydrochloric Acid SCHEMBL10563577 0.74 HTR6 (0.82) HTR6HTR2CHTR2BALDH1A1PNMT
SCHEMBL1945834 0.73 HTR6 (0.85) HTR6HTR2CHTR2BALDH1A1PNMT
SCHEMBL5781207 0.72 HTR6 (0.74) HTR6HTR2CHTR2BPKMPNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487801-B1 7-ARYLSULFONAMIDO-2,3,4,5-TETRAHYDRO-1H-BENZO¬D|AZEPINE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY FOR THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2006-04-19 EP claimed
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity HTR6, HTR4, HTR5A HTR6 1/4885HTR2C 8/4885HTR2B 10/4885
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders HTR6, HTR7, HTR2A HTR6 1/4885HTR2C 6/4885HTR2B 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.